(Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO) "Neuropathic pain remains an under-diagnosed condition in many parts of the world, in large part due ...
Top-Line Results Show Lyrica Met All Co-Primary Endpoints NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study for Lyrica (pregabalin) in patients with Restless Legs ...
Pfizer announced positive Phase 3 study data that evaluated Lyrica (pregabalin) capsules and oral solution as adjunctive therapy for pediatric epilepsy patients aged 4-16 years with partial onset ...
NEW YORK-- (BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today top-line results of a double-blind Phase 4 study evaluating the safety and efficacy of Lyrica® (pregabalin) Capsules CV in ...
Pregabalin (Lyrica® Capsules CV) can significantly improve fibromyalgia pain in people who also are being treated for depression, according to new research. Pregabalin (Lyrica® Capsules CV) can ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
What to do: Check your medication bottle or package. If your prescription is for 50 mg capsules and the bottle contains any 150 mg capsules, or if you are unsure, return it to your pharmacy ...
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study for Lyrica (pregabalin) in patients with Restless Legs Syndrome (RLS) met each of its three co-primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results